57
Participants
Start Date
May 28, 2020
Primary Completion Date
May 4, 2021
Study Completion Date
May 4, 2021
Buprenorphine 0.15 MG
Buprenorphine 0.15mg solution will be added to a 20mL 1% buffered lidocaine solution (paracervical block) which will be administered in the paracervical space prior to osmotic dilator insertion.
Lidocaine 1% Injectable Solution
20mL of 1% buffered lidocaine solution (paracervical block) will be administered in the paracervical space prior to osmotic dilator insertion.
University of California San Diego Health, San Diego
Society of Family Planning
OTHER
University of California, San Diego
OTHER